The WHO estimates that 422 million people worldwide suffer from diabetes, with the majority residing in low- or middle-income ...

The new authorisation has been granted for a single-dose, pre-filled pen device that requires no titration and is approved for use in combination with other glucose-lowering medicines, including ...

Travelling can be thrilling and overwhelming, especially when you’re managing a chronic condition like diabetes. The idea of ...

Quality scores dipped during the COVID-19 pandemic, but are now at or above 2019 levels in areas such as diabetes and asthma management.

A study in people with obesity and diabetes again found CagriSema helps people lose weight, but not by enough to clearly ...

Used sharps, including hypodermic needles for medical injections, require safe storage in an FDA-cleared container made of ...

COMMENT: The new craze of using lower-than-recommended dosages of weight loss drugs to slim down might sound tempting, says ...

Research suggests potential health benefits beyond what popular diabetes and weight-loss drugs were first approved to treat.

Novo Nordisk’s semaglutide diabetes and weight loss drugs, Ozempic and Wegovy, are no longer officially in shortage in the US ...

South Africa's competition watchdog launches a crucial investigation into pharmaceutical giants Novo Nordisk and Sanofi over their insulin pen market practices, amid growing concerns about ...

Here are five recent innovative bioprinting and bioink studies that are building synthetic biological structures.

Health experts are concerned Ozempic and other GLP-1 agonist drugs may be inappropriately prescribed to people experiencing ...